Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$68.26 - $76.19 $290,924 - $324,721
4,262 Added 75.35%
9,918 $755,000
Q1 2024

May 13, 2024

BUY
$67.36 - $77.59 $380,988 - $438,849
5,656 New
5,656 $414,000
Q3 2022

Nov 10, 2022

SELL
$49.9 - $57.32 $35,578 - $40,869
-713 Reduced 4.59%
14,821 $786,000
Q2 2022

Aug 11, 2022

SELL
$49.62 - $58.13 $191,235 - $224,033
-3,854 Reduced 19.88%
15,534 $868,000
Q1 2022

May 12, 2022

SELL
$48.27 - $65.25 $639,625 - $864,627
-13,251 Reduced 40.6%
19,388 $1.1 Million
Q4 2021

Feb 11, 2022

SELL
$59.5 - $67.25 $39.3 Million - $44.5 Million
-661,279 Reduced 95.3%
32,639 $2.14 Million
Q3 2021

Nov 12, 2021

SELL
$60.19 - $75.29 $26,303 - $32,901
-437 Reduced 0.06%
693,918 $45.4 Million
Q2 2021

Aug 12, 2021

BUY
$62.12 - $74.2 $43.1 Million - $51.5 Million
694,355 New
694,355 $51.1 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.